Free shipping— Canada $250+ CAD
PUFFINPEPTIDES
Voting candidateALPROSTADIL research compound previewCatalogue preview · final packaging and presentation may vary if stocked

Five choices across your ballotUse votes only for compounds you would consider ordering

One vote per compoundEach candidate can be selected once on this browser

Flexible interest signalRemove or reassign a vote whenever you like

Help choose what Puffin stocks next
Performance Research

ALPROSTADIL

Alprostadil is prostaglandin E1, a small lipid signalling molecule rather than a peptide. It is studied as a defined reference for vascular smooth-muscle relaxation, cyclic-AMP signalling, and prostaglandin-receptor biology.

Voting round open One active vote per compound
Your ballot0 of 5 votes used

Loading your saved choices…

Interest onlyA vote is not an order, preorder, reservation, payment, or guarantee that this compound will be stocked.

ALPROSTADIL is currently being evaluated through customer voting and is not available to order. Final product specifications and batch documentation will be published only if it joins the catalogue.

Catalogue statusVoting candidate
CategoryPerformance Research
Research focusPGE1 receptor activity
Ballot allowanceOne vote
Research guide

Understanding Alprostadil

Explore the science, research focus, and key information behind this compound.

What is Alprostadil?

Alprostadil offers a defined PGE1 reference for receptor, second-messenger, and vascular-response studies.

What Researchers Study

Researchers examine PGE1 receptor activity, Cyclic-AMP signalling, and Vascular smooth-muscle models.

How Alprostadil Works

Alprostadil engages prostaglandin E receptors and can raise cyclic AMP in responsive smooth-muscle cells. In plain language, the signal can reduce contractile tone, but the response depends on receptor subtype, tissue, concentration, and formulation.

Research at a Glance

PGE1 signalling is well characterized in humans. Alprostadil is used in regulated prescription products, giving the active molecule an established pharmacology. Product-specific formulation, route, dose, sterility, and manufacturing controls remain essential to that evidence. This product is a prostaglandin—not a peptide. Its presence in a peptide catalogue is a merchandising convenience. Researchers should classify and handle it according to its actual chemistry rather than the category around it. Route-specific products are not interchangeable. Approved alprostadil products use different delivery systems and instructions. Those formulation controls shape exposure and cannot be inferred from a generic vial.

Read the full Alprostadil evidence guideStudy design, primary sources, limitations, and unanswered questions.Open guide
Research-use statement

If this candidate is added to the catalogue, it would be offered for controlled laboratory research only. It is not for human consumption and is not represented as a medicine, treatment, supplement, or substitute for an approved product.